Richard Rosenquist
Overview
Explore the profile of Richard Rosenquist including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
307
Citations
6267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pavlova S, Malcikova J, Radova L, Bonfiglio S, Cowland J, Brieghel C, et al.
Hemasphere
. 2025 Jan;
9(1):e70065.
PMID: 39840379
In chronic lymphocytic leukemia, the reliability of next-generation sequencing (NGS) to detect variants ≤10% allelic frequency (low-VAF) is debated. We tested the ability to detect 23 such variants in 41...
2.
Delgado-Vega A, Cederroth H, Taylan F, Ekholm K, Ek M, Thonberg H, et al.
Nat Genet
. 2024 Oct;
56(11):2287-2294.
PMID: 39433890
No abstract available.
3.
Glimelius I, Kleinstern G, Robinson D, Mansouri L, Rostgaard K, Hjalgrim H, et al.
EJHaem
. 2024 Oct;
5(5):998-1004.
PMID: 39415908
Background: Chronic lymphocytic leukemia (CLL) is a heterogeneous disease. Whereas some patients have an indolent disease, others experience an aggressive course and early death. Our aim was to investigate if...
4.
Brahimllari O, Eloranta S, Georgii-Hemming P, Haider Z, Koch S, Krstic A, et al.
Health Informatics J
. 2024 Oct;
30(4):14604582241290725.
PMID: 39394057
Massively parallel sequencing helps create new knowledge on genes, variants and their association with disease phenotype. This important technological advancement simultaneously makes clinical decision making, using genomic information for cancer...
5.
Hagerstrand D, Oder B, Cortese D, Qu Y, Binzer-Panchal A, Osterholm C, et al.
Leukemia
. 2024 Sep;
38(11):2429-2442.
PMID: 39261602
SF3B1 mutations are recurrent in chronic lymphocytic leukemia (CLL), particularly enriched in clinically aggressive stereotyped subset #2. To investigate their impact, we conducted RNA-sequencing of 18 SF3B1 and 17 SF3B1...
6.
Thangavelu T, Wirta V, Orsmark-Pietras C, Cavelier L, Fioretos T, Barbany G, et al.
J Med Econ
. 2024 Aug;
27(1):1053-1060.
PMID: 39101813
Aims And Background: Whole-genome sequencing (WGS) is increasingly applied in clinical practice and expected to replace standard-of-care (SoC) genetic diagnostics in hematological malignancies. This study aims to assess and compare...
7.
Stamatopoulos K, Pavlova S, Al-Sawaf O, Chatzikonstantinou T, Karamanidou C, Gaidano G, et al.
Hemasphere
. 2024 Jul;
8(7):e113.
PMID: 39035106
Patients with chronic lymphocytic leukemia (CLL) exhibit diverse clinical outcomes. An expanding array of genetic tests is now employed to facilitate the identification of patients with high-risk disease and inform...
8.
Orsmark-Pietras C, Lyander A, Ladenvall C, Hallstrom B, Staffas A, Awier H, et al.
Genes Chromosomes Cancer
. 2024 Jul;
63(7):e23257.
PMID: 39031442
Gene panel sequencing has become a common diagnostic tool for detecting somatically acquired mutations in myeloid neoplasms. However, many panels have restricted content, provide insufficient sensitivity levels, or lack clinically...
9.
Tesi B, Lagerstedt Robinson K, Abel F, Diaz De Stahl T, Orrsjo S, Poluha A, et al.
Lancet Reg Health Eur
. 2024 May;
39:100881.
PMID: 38803632
Background: Childhood cancer predisposition (ChiCaP) syndromes are increasingly recognized as contributing factors to childhood cancer development. Yet, due to variable availability of germline testing, many children with ChiCaP might go...
10.
Malcikova J, Pavlova S, Baliakas P, Chatzikonstantinou T, Tausch E, Catherwood M, et al.
Leukemia
. 2024 May;
38(7):1455-1468.
PMID: 38755420
In chronic lymphocytic leukemia (CLL), analysis of TP53 aberrations (deletion and/or mutation) is a crucial part of treatment decision-making algorithms. Technological and treatment advances have resulted in the need for...